It is the first company to move to Mind in Milan, the innovation district born on the ‘ashes’ of Expo 2015. By choosing it as its new headquarters, AstraZeneca aims to “fit into a research ecosystem” and today unveils its mission: “Accelerate”. Also on investments, which from 24 million euros dedicated to Research and Development will increase to 48 million euros, “thus doubling the benefits for the National Health Service to over 200 million”. These are some of the data contained in the ‘AZ Valore’ document, developed by ‘The European House – Ambrosetti’, with which the Anglo-Swedish multinational illustrates its commitment and the production of value for Italy: 2 billion euros of contribution to GDP in next 3 years, 3 thousand jobs activated in the supply chain in 2020 which will become 6,000 in 2023.
The document was presented today during an institutional event held at the Milano Innovation District, which originates from the reconversion of the Expo buildings according to circular economy principles. “Mind’s ecosystem will allow us to accelerate the development of ideas and their transformation into concrete projects to support patients and the whole society – says Lorenzo Wittum, president and CEO of AstraZeneca – We are convinced that innovation and research are needed. collaboration, simplification and that the contamination between different worlds is fundamental “.
“Research, innovation and the future are the keywords of Arexpo for the development of Mind, a district that, starting from the legacy of Expo 2015, focuses on life sciences, on people’s well-being. To do this in the best possible way – says Igor De Biasio, director Arexpo delegate – the right recipe is that of collaboration between important public and private entities that know how to face the challenges of a world that changes every day. The choice of a major international player such as AstraZeneca to be the first company to join Mind is for Arexpo the concrete demonstration of the attractiveness of our innovation district at national and international level “.
“AstraZeneca – concludes Andrea Ruckstuhl, Head of Italy and Continental Europe at Lendlease, responsible for the design and construction of the Mind district – will be the first company to establish itself in the innovation district and is one of the founders of Federated Innovation, a model that Lendlease has promoted and created, the first model that brings together private companies and public institutions in an alliance that aims to generate innovation in all the main disciplines of the future “
#AstraZeneca #moves #Mind #Milano #investments #research